Skip to the content
The approval comes days after the NIH announcement of preliminary results showing a four-day shortening of hospital stays after treatment with the drug.
View Entire Post ›
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT Privacy & Cookies Policy